Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Intravitreal Aflibercept Injection for the Treatment of Radiation Maculopathy

NCT02586727 is registered in ClinicalTrials.gov with Larkin Community Hospital as lead sponsor.

NCT NCT02586727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02586727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Intravitreal Aflibercept Injection for the Treatment of Radiation Maculopathy
Lead sponsor
Larkin Community Hospital
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2015
Completion date
August 31, 2020
Enrollment
40 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adverse effect of radiation therapy